| 注册
首页|期刊导航|中国药房|我国生物医药产业发展水平的因子分析法实证研究

我国生物医药产业发展水平的因子分析法实证研究

陈韫伟 李野 许晶

中国药房2011,Vol.22Issue(41):3844-3846,3.
中国药房2011,Vol.22Issue(41):3844-3846,3.

我国生物医药产业发展水平的因子分析法实证研究

Empirical Study by Factor Analysis in Biomedical Industry Development in China

陈韫伟 1李野 1许晶1

作者信息

  • 1. 沈阳药科大学工商管理学院,沈阳市110016
  • 折叠

摘要

Abstract

OBJECTIVE: To provide a reference for the relevant biomedical industry departments which intend to take measures. METHODS: Factor analysis was used to construct the comprehensive evaluation system for biomedical industry development of 28 areas. The development of biomedical industry in China was evaluated by 14 economic indicators from scale level, profitability, operation capacity and development capacity. RESULTS & CONCLUSIONS: The level of biomedical industry development of each area is not balanced. Scale level is important to improve the level of biomedical industry development, and profitability, operation capacity and development capacity also contribute to comprehensive development. Recognizing the advantages and disadvantage and taking relevant measures are crucial for each area to develop biomedical industry in healthy way in the future. It is suggested to enlarge the scale of biomedical industry, promote the sustained and steady growth of biomedical industry, strengthen research and develop effective management.

关键词

生物医药产业/因子分析法/指标/评价

Key words

Biomedical industry/ Factor analysis/ Index/ Evaluation

分类

管理科学

引用本文复制引用

陈韫伟,李野,许晶..我国生物医药产业发展水平的因子分析法实证研究[J].中国药房,2011,22(41):3844-3846,3.

中国药房

OACSCDCSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文